Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 5.89% | 1.475 M | 100.23% | 5.90% | 2054-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 5.60% | 4.352 M | 74.74% | 3.30% | 2040-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 5.54% | 1.67 M | 70.08% | 3.55% | 2050-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 5.52% | 660 K | 66.52% | 3.35% | 2051-09-02 | 700 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5.41% | 2.014 M | 99.95% | 5.40% | 2034-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5.08% | 10.314 M | 85.40% | 2.20% | 2030-09-02 | 996.812 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5.02% | 601 K | 83.28% | 2.15% | 2031-09-02 | 600 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5.00% | 48 K | 100.64% | 5.15% | 2029-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 4.68% | 7.513 M | 92.26% | 1.75% | 2027-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4.26% | 11.145 M | 97.01% | 1.20% | 2025-09-02 | 999.962 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2.43% | 0 | 98.72% | 2.20% | 2030-09-02 | 3.188 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1.59% | 0 | 99.62% | 1.20% | 2025-09-02 | 38 K USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |